Hepatocytes and cholangiocytes self-renew following liver injury. Following severe injury hepatocytes are increasingly senescent, but whether hepatic progenitor cells (HPCs) then contribute to liver regeneration is unclear. Here, we describe a mouse model where the E3 ubiquitin ligase Mdm2 is inducibly deleted in more than 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes expressing p21. This results in florid HPC activation, which is necessary for survival, followed by complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for liver disease.
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Hepatocytes and cholangiocytes self-renew following liver injury. Following severe injury hepatocytes are increasingly senescent, but whether hepatic progenitor cells (HPCs) then contribute to liver regeneration is unclear. Here, we describe a mouse model where the E3 ubiquitin ligase Mdm2 is inducibly deleted in more than 98% of hepatocytes, causing apoptosis, necrosis and senescence with nearly all hepatocytes expressing p21. This results in florid HPC activation, which is necessary for survival, followed by complete, functional liver reconstitution. HPCs isolated from genetically normal mice, using cell surface markers, were highly expandable and phenotypically stable in vitro. These HPCs were transplanted into adult mouse livers where hepatocyte Mdm2 was repeatedly deleted, creating a non-competitive repopulation assay. Transplanted HPCs contributed significantly to restoration of liver parenchyma, regenerating hepatocytes and biliary epithelia, highlighting their in vivo lineage potency. HPCs are therefore a potential future alternative to hepatocyte or liver transplantation for liver disease.
Liver transplantation is the only effective cure for advanced liver disease. However, a global shortage in donor organs means that many patients die waiting for suitable organs. Hepatocyte cell therapy is an attractive alternative to liver transplantation 1, 2 . Hepatocytes have a high replicative potential in vivo 3, 4 ; however, hepatocyte isolation is technically demanding and requires cadaveric liver donation, and hepatocytes cannot be expanded effectively in vitro 5 . Ductular reactions are activated in chronic liver injury and are thought to include putative hepatic progenitor cells (HPCs) with the potential to regenerate hepatocytes and cholangiocytes 6, 7 . However, the significance of this regenerative pathway is unclear. Recent studies have sought to identify HPCs using surface markers 8, 9 or in vivo lineage tracing [10] [11] [12] [13] . These studies demonstrated that HPCs arise within the liver, engraft the parenchyma 14 and may have some differentiation capacity but did not regenerate significant quantities of liver parenchyma [11] [12] [13] . Only if HPCs have regeneration capacity, are expandable in vitro and transplantable would they be a potential future therapeutic target. Many dietary and chemical models of injury have been exploited to investigate the biology of HPCs (refs 15-17) .
Experiments utilizing hepatocyte lineage tracing in mice have shown in various liver injury models that hepatocytes regenerate themselves without any significant contribution from HPCs (refs 18,19) . This calls into question the nature and role of HPCs in liver injury and regeneration 20 . Further experiments in mice have shown that hepatocytes can change into a biliary ductular phenotype 21, 22 and then later re-differentiate into hepatocytes 23 . In advanced human liver disease there is often widespread hepatocyte senescence, that is, an irreversible block to hepatocyte replication, indicated by p21 or p16 positivity. In this setting, ductular reactions develop; however, the functional role of putative HPCs in human liver disease is difficult to discern in the absence of lineage tracing 24 . The question arises as to whether mouse models of liver injury adequately reflect human disease. In the rat, complete suppression of hepatocyte proliferation can be achieved using chemical toxins, which provokes an extensive ductular/HPC response which is thought to regenerate parenchyma, although lineage tracing studies are required to formally prove this 25 . The transdifferentiation of hepatocytes into biliary ductules
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is damage dependent and negligible unless significant injury is induced 26 . To model the human (and rat) situation, we have utilized a genetic means of inducing hepatocyte injury and senescence in adult mouse liver. We have exploited an AhCre system 27 with an Mdm2 locus (ref. 28) , which remains inactive until induced with β-naphthoflavone (βNF). Following induction with βNF, Cre recombinase is expressed in >98% of hepatocytes where it renders Mdm2 inactive. Mdm2 is an E3 ubiquitin-protein ligase that functions to degrade TRP53 (p53). Inactivation of Mdm2 results in upregulation of p53 and induces p53-mediated hepatocyte death and senescence. This results in rapid activation of HPCs throughout the liver, which proliferate, differentiate into hepatocytes, and completely restore architecture and function.
A highly purified population of HPCs were isolated on the basis of a defined surface antigen profile and expanded in vitro. HPCs were transplanted in vivo in a non-competitive model of liver regeneration where they expand massively and differentiate, reconstituting the liver, significantly improving liver function and architecture.
RESULTS

Transgenic targeted hepatocellular injury as a model of whole-organ repair
To determine whether endogenous ductular cells give rise to hepatocytes we analysed a lineage tracing system using the CDE (choline-deficient ethionine-supplemented) diet-recovery model 11 ( Supplementary Fig. 1a ). To label biliary/ductular cells we used the Krt19
CreERT LSL tdTomato mouse and found labelling to be strictly limited to ducts in the uninjured liver with zero hepatocyte labelling (Supplementary Fig. 1b) . Following CDE-recovery there was a minor degree of tracing into hepatocytes ( Supplementary Fig. 1b,c) , indicating that in this model the ductular-hepatocyte regeneration pathway is insignificant. We found minimal hepatocyte senescence ( Supplementary  Fig. 1b ), in contrast to advanced human diseases and rat models of HPC activation where high levels of hepatocyte senescence occur 29 .
To analyse liver regeneration in advanced injury we therefore studied a model of induced hepatocyte senescence in mouse.
The activation and proliferation of HPCs in vivo requires both hepatocellular injury and inhibition of hepatocyte replication. To achieve this we utilized the AhCre transgenic line, which contains the rat Cyp1A1 promoter cloned upstream of Cre recombinase, and we combined this line with a transgenic Mdm2 locus in which exons 5 and 6 are flanked with loxP sites (Mdm2 flox/flox ), to generate AhCre + Mdm2 flox/flox mice 18, 19 . Following βNF induction (Fig. 1a) , Cre recombinase is expressed in hepatocytes and Mdm2 is rendered inactive ( Mdm2).
Uninduced AhCre + Mdm2 flox/flox mice have normal hepatic architecture and do not express detectable p53 protein in hepatocytes (Fig. 1b) . Two days following induction, and Cre activation, with 20, 40 or 80 mg kg −1 of βNF, rapid expression of p53 protein was observed in hepatocyte nuclei in a dose-dependent manner (Fig. 1b,c) ; however, following βNF administration to Mdm2 flox/flox animals lacking the AhCre transgene, we found no expression of p53 protein, confirming that p53 expression is a consequence of Cre activity and Mdm2 loss (Fig. 1d) . We also observed expression of p21 protein in hepatocytes following βNF administration (Fig. 1e) but not in Cre − animals (Fig. 1f) . To validate Mdm2 recombination in this system following Cre activation, we isolated a highly purified population of hepatocytes and non-parenchymal cells (NPCs) two days following high-dose (80 mg kg −1 ) βNF administration. We evaluated the presence of both exon 5 (which would be lost following Cre-mediated recombination) and exon 3 (which would remain intact following Cre-mediated recombination), thereby offering an internal control. In hepatocytes there was a 96.8% reduction in the quantity of genomic Mdm2 exon 5 following recombination but only a 0.8% reduction in NPCs from the same cohort ( Fig. 1g and Supplementary Fig. 2a-d) indicating that the AhCre transgene is highly specific in recombining Mdm2 in hepatocytes.
Following βNF administration, Mdm2 mice developed jaundice after three days and required humane euthanasia by day 8 (Supplementary Table 1 and Supplementary Fig. 8 ). Serum markers for liver injury (aspartate aminotransferase, bilirubin, alkaline phosphatase and alanine transaminase) were all elevated and serum albumin levels fell, signifying injury and impaired synthetic function of the livers of Mdm2 mice (Fig. 1h-j and Supplementary Fig. 2e,f) . This reduction in functionality is associated with hepatocyte necrosis by haematoxylin and eosin (H&E) staining, which shows clear disruption of the hepatic architecture as well as increased positivity of lactate dehydrogenase staining ( Fig. 1k and Supplementary Fig. 2h ). The levels of apoptosis in Mdm2 mice were determined through TUNEL staining, which was absent in uninduced AhCre + Mdm2 flox/flox animals; however, we found clear positive cells throughout the parenchyma in AhCre + Mdm2 flox/flox mice that had received βNF (Fig. 1l) . Further to this, we found increased messenger RNA expression of the p53-dependent apoptotic gene Bax1 (Supplementary Fig. 2g ) throughout the 8-day time course in Mdm2 mice.
Widespread hepatocyte injury promotes a ductular reaction
Following βNF administration we found small cells appearing in the livers of Mdm2 mice that did not upregulate p53. We examined the ductular reaction in Mdm2 livers to ascertain whether HPCs arise in this model. In the uninduced liver, panCK is expressed throughout the biliary tree and is restricted to the portal tract (Fig. 2a) . Eight days following induction of the AhCre transgene, the number of panCK-positive ductular reactions, containing putative HPCs, increases and are found migrating as cords throughout the liver parenchyma (Fig. 2b,c and Supplementary Fig. 3a-c) . Following AhCre induction, the migrating cords of HPCs also express the HPC markers EpCAM and CD24 ( Fig. 2d and Supplementary Fig. 3d ). In contrast, we found that the cell population that express EpCAM and CD24 are restricted to the biliary epithelium in the healthy liver (Fig. 2e) . We compared our ∆Mdm2 progenitor cell profile with those that are generated in the widely studied CDE model of liver damage and regeneration using fluorescence-activated cell sorting (FACS). Here we found an expansion of a cell population that expresses the HPC markers EpCAM, CD24 and CD133 (Fig. 2f ) in CDE; critically, our Mdm2 HPCs express the same surface antigens at comparable levels. In line with this increase in HPC number, we observed a significant increase in mRNA expression of HPC markers EpCAM, Dlk1, Krt19 and Ascl2 over 8 days in the Mdm2 line (Fig. 2g,h and Supplementary Fig. 3e,f) . The extent of the ductular reaction in the Mdm2 was significantly greater than in the CDE diet ( Supplementary Fig. 3g ). In the Mdm2 livers, Sox9-positive p53 p53 p53 p53 p53 p53 p53 5 53 53  p53 p53 3 3  p5 p53 p53 3 3 3 3  53 3 3 3 3  p53 p53 3 3 3 3 3 3 3  53  p53 53 53 3  p53 53 53 5 5 53 53  p p  p53 p5 p53 p53 p53 p53 p53 p53 p53 p53 p53 p53 p53 p53 p5 p53 p53 p53 p53 p p p53 p53 p53 p53 p53 3  p53 3  p53 3  p53 p53 p53 53  p p53 p53 p53 53  p p p p5 53 5 5 5 5 53 3  53 53  p5 WT/WT and uninduced controls (mean ± s.e.m., (h) P = 0.042, (i) P = 0.046, (j) P = 0.026, one-way ANOVA; n = 3 mice in each group, except day 8 in which n = 1 owing to mortality). HPCs did not express CYP2D6 (Fig. 2i) . Furthermore, HPCs were not affected by the Cre system in response to the βNF induction, as they lacked upregulation of p53 (Fig. 2j) , and are proliferative following βNF administration and recombination of the Mdm2 BrdU-positive hepatocytes 8 days following AhCre induction, suggesting that hepatocytes arise from BrdU-positive HPCs in this model. Importantly, we also found that 2 days after induction there are no BrdU-positive hepatocytes adjacent to BrdU-positive HPCs, suggesting that proliferation of HPCs themselves does not lead to hepatocyte proliferation ( Supplementary Fig. 3h ).
Large-scale hepatocyte replacement can arise from endogenous HPCs
The AhCre + Mdm2 flox/flox model results in massive hepatocyte injury, where more than 96% of hepatocytes accumulate p53, and activates a florid HPC response. To investigate how significant the HPC contribution is to regeneration we sought to induce the Mdm2 transgene and follow progenitor cells out to 6 months, to evaluate whether they can reconstitute the liver efficiently.
To avoid the early mortality observed in AhCre Table 1 and Supplementary Fig. 8 ). In 
AhCre
+ Mdm2 flox/− mice, the onset of liver injury and clinical signs of acute disease, demonstrated through necrosis and apoptosis by H&E and TUNEL staining (Fig. 3a,b) , together with tachypnoea, hunching, prostration and bilirubinuria, occur between 14 and 21 days following AhCre activation, all of which are delayed in the Mdm2 flox/− compared with the Mdm2 flox/flox mice given the same induction regime. Concurrently, HPC activation was more gradual than in the AhCre + Mdm2 flox/flox counterparts and arose from day 14 post Mdm2 deletion (Fig. 3c) . The most likely explanation for this delay is that compensatory changes occur in the hepatocytes that already lack one allele, so when the second allele is removed the effect is less pronounced. A similar effect of Mdm2 haploinsufficiency has been described in the context of tumour development In AhCre + Mdm2 flox/− mice following βNF administration, a large proportion developed liver damage and then subsequently made full recoveries with dissipation of liver injury and the ductular reactions ( Fig. 3f ) by 6 months. As the AhCre is highly efficient in the liver we used the presence of nuclear p53 in hepatocytes to ascertain the HPC-mediated hepatocellular regeneration. As anticipated, two days following βNF we found that most hepatocytes expressed the p53 protein (98.9%; Fig. 4a,b) . In addition to the high level of p53 in the liver, almost all hepatocytes (99.96%) express the senescence marker p21, suggesting that these cells enter either direct or indirect senescence 2 days following βNF (Fig. 4c,d ). At 19 days following induction, p53 staining in hepatocytes was more heterogeneous, with 93.5% of hepatocytes still expressing p53 (Fig. 4a,b ). Six months following induction of Cre recombinase, hepatocytes were largely p53 negative (only 0.14% of hepatocytes were positive). The sequential dilution of p53 positivity from the hepatocyte population reflects the progressive replacement of Mdm2-negative hepatocytes from the parenchyma by HPC-derived (Mdm2 intact, p53 low) hepatocytes.
To confirm that this loss of p53 positivity was not due to downregulation of p53 by other mechanisms, we used the AhCre + Mdm2 flox/− mice crossed onto a silenced R26RLacZ reporter. Following recombination, LacZ expression could be detected throughout the intestine and liver. Loss of reporter was seen over 6 months, indicating that replacement of the recombined epithelium occurs from a non-recombined source (Fig. 4e) . Following recovery of AhCre + Mdm2 flox/− mice, no animals developed liver tumours or notable fibrosis (Fig. 4f) .
Endogenous HPCs are required for adult liver regeneration following Mdm2 loss
In our AhCre + Mdm2 flox/− mouse model we wanted to evaluate the kinetics of cell replacement from p53-negative HPCs. Proliferating hepatocytes, positive for Ki67, were arranged in cord-like formations, with each cord of dividing hepatocytes being in contact with the distal tips of the ductular reaction (Fig. 5a ). This evidence, although indirect, suggested a role for HPCs in either supporting hepatocyte proliferation or differentiating into hepatocytes.
Fn14 has been identified as a critical receptor for mitogenic stimulation of HPCs (refs 31-34) . To confirm that the regeneration we see in the AhCre Mdm2 system is a direct result of HPC activation and differentiation, and not due to a small number of hepatocytes that escape Mdm2 recombination, we crossed the AhCre + Mdm2 flox/flox mouse onto an Fn14 null (Fn14 KO ) background 34 . We induced the AhCre + Mdm2 flox/flox Fn14 KO mouse and tracked the fate of these animals over 30 days (Fig. 5b) . In our AhCre + Mdm2 flox/flox model where Fn14 is intact we detect upregulation of Fn14 mRNA following induction with βNF over four days (Fig. 5c) . Following Cre induction, Fn14 KO Mdm2 animals demonstrated a significantly reduced survival, and all had to be euthanized within 10 days (Fig. 5d) , unlike corresponded with failed ductular expansion (Fig. 5e,f) , indicating that in the AhCre + Mdm2 flox/− mouse, HPCs are critical for hepatic regeneration. HPCs had a corresponding reduction in NFκB activity (Fig. 5g) , a downstream mediator of TWEAK/Fn14 signalling 33 . We treated Mdm2 mice (which are WT for the tweak receptor Fn14) throughout the onset of injury with 4 doses of intravenous TWEAK (Fig. 6a) . At 4 days following activation of Cre, animals that had been given TWEAK had significantly increased numbers of ductular cells versus vehicle alone (Fig. 6b,c) . TWEAK-treated Mdm2 mice also had a higher frequency of p53-negative hepatocytes adjacent to ductular cords (Fig. 6d) . To confirm that the effect of TWEAK is on ducts instead of hepatocytes, we isolated hepatocytes from βNF-induced animals and did not observe upregulation of Fn14 in hepatocytes after injury (Fig. 6e) . These data suggest that following loss of Mdm2 in
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+ marks a population of bipotent HPCs
The AhCre + Mdm2 flox/flox model demonstrates the efficacy of adult HPCs to regenerate the adult liver. In human disease, cells analogous to the murine HPCs arise in response to biological or chemical damage 24, 35 (not typically genetic alteration), so to assess whether ex vivo HPCs can also significantly repopulate the adult liver we used a chemical model of hepatocellular disease, the murine CDE diet, previously employed to trace the fate of HPCs in vivo 11, 16, 17 . Isolation of these HPCs by FACS has been variable 8, 36, 37 ; therefore, we used HPC markers described in the literature, in combination, to identify the most potent HPC sub-population.
The CDE diet resulted in ductular reactions arising from the terminal ducts of the portal tracts compared with control diet (Fig. 7a,b) . Within the panCK-expressing ductular reactions, we observe a subpopulation of HPCs that express the surface markers EpCAM and CD24; whereas EpCAM is very specific for ductular cells, CD24 labels both HPCs and a population of hepatocytes in vivo (Fig. 7c and Supplementary Fig. 3d ). To exclude these CD24-positive hepatocytes, and to ascertain whether these CD24
+ EpCAM + cells were bona fide HPCs, we used FACS to isolate multiple candidate HPC populations. We negatively selected for haematopoietic (CD45), endothelial (CD31) and erythroid (Ter119) lineages and then positively selected for EpCAM, CD24 and CD133 (Fig. 7d) Besides an increase in total NPC population, all three populations were enriched in the NPC fraction of livers from mice fed the CDE diet compared with the control diet (Fig. 7e) . These three populations were plated at clonal density to assess their colony-forming potential. Fig. 7f,g ).
The defined population of HPCs can be expanded in vitro
Over six weeks, cdHPCs expand and proliferate in vitro. Historically, expanding HPCs has been hampered by cells differentiating following replating; we therefore adapted a new method for passaging these cells where, rather than being passaged as a single-cell suspension, they are detached using highly diluted trypsin and lifted and replated as colonies, ensuring that cell-cell contact is maintained 38 . Using this method we found that the viability and phenotypic stability of passaged cdHPCs increased (Supplementary Fig. 4a ). In our assay, only the cdHPC population can be expanded whilst maintaining an epithelial morphology; the other two populations failed to maintain any epithelial phenotype. The expanded cdHPC population can be maintained long term in vitro (more than 30 passages and up to a year) and remains chromosomally stable having a normal karyotype (Fig. 7h) . The in vitro-expanded cdHPCs maintained the co-expression of HPC markers EpCAM, CD24 and CD133 (Supplementary Fig. 4b ). Expanded cdHPCs highly express HPC-related genes relative to housekeeping gene compared with hepatocytes ( Supplementary Fig. 4c,d ). Expanded cdHPCs maintained their HPC characteristics and were positive for a suite of markers (Sox9, CD44, Fn14, OPN1 and panCK) which have been used to define HPCs in vivo and the expression of these markers was maintained after 30 passages (Fig. 7i and Supplementary  Fig. 4e,f) . We did not observe a significant change in the expression of most HPC-related genes such as EpCAM, Krt19, Spp1 and Sox9, or Alb after long-term passaging, although Lgr5 expression increased ( Supplementary Fig. 4e ). After in vitro expansion, mean cell size reduced after 10 passages; however, no significant changes in elongation assessed by cell roundness, or cell width to length ratio were seen ( Supplementary Fig. 4g ). We calculated that in our in vitro expansion system each cell has divided around 32 times at passage 10 ( Supplementary Fig. 4h ). cdHPCs did not express endothelial (CD31), haematopoietic (CD45) or mesenchymal (GFAP and desmin) markers ( Supplementary Fig. 5a,b) . To ascertain the bipotentiality of cdHPCs we differentiated them towards biliary or hepatic lineages. Following three-dimensional culture of cdHPCs in Matrigel, we observed cells forming tubules, which had a branched morphology and lumen ( Supplementary Fig. 5c ) and expressed the activated bile duct marker MIC1C3 and the biliary transcription factor HNF1β (Supplementary Fig. 5c ). For hepatocyte differentiation, cdHPCs were treated with recombinant WNT3A, which has been shown in other systems to promote hepatocyte differentiation 39 . Following rWNT3A treatment, clusters of cdHPCs increased in size and became hexagonal in shape, and increased glycogen storage as demonstrated by periodic acid-Schiff (PAS) staining ( Supplementary  Fig. 5d ). Murine albumin increased at the transcript level and as a protein in the culture medium ( Supplementary Fig. 5e , upper histograms). Concurrent with this upregulation, we found loss of the biliary-and progenitor-associated genes Krt19, Epcam, Dlk1 and Afp and upregulation of the hepatocyte transcription factor Hnf1a ( Supplementary Fig. 5e, lower Fig. 6a-c) .
To confirm the biliary/ductular origin of the cdHPCs, we isolated cdHPCs from tamoxifen-induced Krt19
CreERT LSL tdTomato mice without liver injury, during CDE injury, and 2 weeks after CDE injury (Fig. 7j) . The recombination efficiency of Krt19-expressing cells after tamoxifen administration in the Krt19
CreERT LSL tdTomato mice was 62% (Fig. 7k) . Zero Tomato expression was observed in the hepatocytes in any animal (Supplementary Fig. 1a) . Likewise, the cdHPCs from tamoxifeninduced Krt19
CreERT LSL tdTomato mice without liver injury were 70% Tomato + demonstrating their ductular origin. This percentage of TdTomato-expressing cdHPCs remained constant before, during CDE injury, and after recovery from CDE injury (Fig. 7l,m) , arguing against a significant non-ductular contribution to this population.
In vitro-expanded HPCs can repopulate the liver after hepatocellular injury
To ascertain the in vivo liver repopulating potency of cdHPCs, we performed transplantation studies using cdHPCs. cdHPCs were transfected with a plasmid expressing CAG-GFP and stably transfected clones selected (Fig. 8a) . GFP-cdHPCs (5 × 10 6 ) were transplanted intrasplenically into the AhCre + Mdm2 flox/flox mice that had previously received a low dose of βNF (10 mg kg −1 ) to induce hepatocellular injury. Following transplantation, recipient AhCre + Mdm2 flox/flox mice were given repeated doses of βNF (20 mg kg −1 ) every 10 days to progressively ablate endogenous Mdm2 loxP hepatocytes ( Fig. 8a and Supplementary Table 1) . Three months following transplantation, large patches of GFP + cells were observed in the transplanted liver compared with controls (Fig. 8b) . GFP-positive cells in the parenchyma were large and morphologically consistent with hepatocytes ( Fig. 8c and Supplementary Fig. 7a ). Transplanted animals had significantly improved liver histology with stronger glycogen staining (Fig. 8d top and middle panel) , less liver scarring, (Fig. 8d bottom panel and Fig. 8e ) and increased serum albumin levels compared with controls (Fig. 8f) . The GFPexpressing, cdHPC-derived cells co-expressed the hepatocyte markers HNF4α and CYP2D6 and were found in patches adjacent to host GFP-negative hepatocytes ( Fig. 8g and Supplementary Fig. 7b ). Small GFP-positive ductular cells were seen that expressed panCK and SOX9 (biliary markers), indicating bi-lineage differentiation of transplanted cdHPCs in vivo (Fig. 8h) . These GFP + cells were found in both bile ducts and cords of ductular cells alongside host ductular cells (Supplementary Fig. 7b ). cdHPC hepatocytes were proliferating (Ki67+) in the recipient liver at 3 months following transplantation, whereas there was little proliferation in the endogenous hepatocytes of AhCre + Mdm2 flox/flox recipient mice. Concurrently, more senescent cells in the non-transplanted group were observed with p21 staining (Supplementary Fig. 7c) . 
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DISCUSSION
The liver regenerates through hepatocyte proliferation following moderate liver injury, and hepatocyte cell therapy is a potential alternative to liver transplantation 40, 41 . Liver regeneration following chronic or severe liver injury is less well defined. HPCs are activated during chronic liver disease when hepatocyte proliferation is impaired 15, 42, 43 ; however, whether these HPCs regenerate parenchyma is controversial 11, 21, 44, 45 . Using targeted deletion of Mdm2 in mouse hepatocytes, we have demonstrated that HPC activation is sufficient to regenerate a large proportion of the liver parenchyma. In our model, on Cre activation most hepatocytes (98.9%) accumulate p53, inducing senescence. To address the possibility that the 1.1% of unrecombined hepatocytes may regenerate the liver, we investigated the degree of hepatocyte senescence by p21 staining. Although the proportion of p53-high hepatocytes was 98.9%, almost all hepatocytes (99.96%) were p21 positive, possibly reflecting either under-detection of p53 by immunohistochemistry or the occurrence of spreading senescence as previously reported in vivo and in vitro [46] [47] [48] . The proliferation of p21-positive hepatocytes is irreversibly inhibited 49 making it unlikely that p21-positive hepatocytes contribute to regeneration. Furthermore, proliferating hepatocytes were located at the distal tips of the HPC-containing ductular reactions following βNF induction, suggesting that HPCs contribute to the formation of new p21-negative hepatocytes that are capable of proliferation.
To further investigate the importance of HPC activation, we used a model deficient in Fn14, a receptor for the HPC mitogen TWEAK (refs 33,34) . Mice with Fn14 knockout do not mount an appropriate ductular reaction, and have increased mortality. Administration of TWEAK enhanced the ductular reaction in AhCre + Mdm2 flox/flox mice following liver injury. These findings suggest that the TWEAK/Fn14-mediated ductular reaction is required to adequately regenerate liver parenchyma following such damage.
It has been shown that EpCAM + cells isolated from human liver can be expanded as organoids in vitro 50 . Whether these cells can regenerate large amounts of liver parenchyma will be important for their development as a human cell therapy. Here, we demonstrate that large-scale therapeutic liver repopulation can be achieved by transplanted HPCs.
+ HPCs have a high colony-forming capacity and are of biliary origin. Using the Krt19
CreERT LSL TdTomato lineage tracing model, we found that the degree of hepatocyte formation from ductular cells in the CDE diet and recovery model is limited 13, 21, 45 ; we speculate that this is due to the mild liver injury and lack of hepatocyte senescence, compared with advanced human liver disease 51 . This lack of hepatocyte senescence in the CDE model thereby allows hepatocytes to regenerate themselves without recourse to a second tier of regeneration.
Although previous studies have isolated putative HPCs using FACS isolation, these techniques are based on single selection markers 8, 37 or did not completely exclude other NPC populations 37, 52 . We investigated multiple potential HPC populations by using a highly stringent FACS gating strategy without the need for a transgenic reporter. This is important as HPCs share markers with cholangiocytes and a defined selection strategy is required to reduce impurity if this is going to be translated into human studies. We have overcome the difficulty of expanding HPCs in vitro in monolayer conditions whilst maintaining their karyotypic and phenotypic stability. The
+ HPC population is extremely rare in healthy liver, making their isolation from healthy tissue logistically challenging. Furthermore, the liver repopulating capacity of these cells in a healthy liver is likely to be insignificantprevious lineage tracing studies have shown no contribution from HPCs to hepatocytes in healthy liver 11, 44 and hepatocytes are the primary source of regeneration in normal liver homeostasis 3 . Together, our data suggest the existence of a facultative and functionally significant HPC population that does not contribute to homeostatic repair, but is activated in severe liver injury where hepatocyte senescence is widespread. We have used the term HPC throughout given the data confirming genuine progenitor characteristics of these cells within the ductular reaction; however, in the absence of this functional evidence the term ductular cell may be more accurate.
So far, the repopulation capacity of transplanted HPCs has been limited and their ability to improve the structure of chronically damaged liver unproven. Using repeated rounds of hepatocyte senescence and injury in the AhCre + Mdm2 flox/flox mice combined with HPC transplantation we found that the progeny of the transplanted HPCs can proliferate long term and regenerate large areas of normal parenchyma. The transplanted HPCs demonstrated bi-lineage differentiation into large numbers of hepatocytes and cholangiocytes in vivo causing significant structural and functional improvement of the damaged liver, with reduced scarring and increased serum albumin in transplant recipients. Our characterization of a defined population of HPCs indicates their biological significance and future therapeutic potential for the treatment of human liver disease.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3203
Animal models. The animals used in this study were all on a C57Bl/6 background aged within 8-12 weeks old at the start of the experiments; both male and female mice were used. Animals were housed in a specific pathogenfree environment and kept under standard conditions with a 12 h day/night cycle and access to food and water ad libitum. All animal experiments were carried out under procedural guidelines, severity protocols and with ethical permission from the Animal Welfare and Ethical Review Body (AWERB) and the Home Office (UK). Power calculations were not routinely performed; however, animal numbers were chosen to reflect the expected magnitude of response taking into account the variability observed in previous experiments. AhCre + . Genotyping was performed for AhCre using 5 -CCTGACTAGCATGGCGATAC-3 (forward) and 5 -ATTGCCCCTGTTTC ACTATC-3 (reverse) primers and Mdm2 as previously described 28 . AhCre was induced by intra-peritoneal (i.p.) injection of β-naphthoflavone (βNF, Sigma) at 20-80 mg kg −1 , prepared previously under sterile conditions at 1% (w:v) in corn oil. K19Cre was induced by 3 individual i.p. injections of tamoxifen (20 mg ml −1 , Sigma) at the dose of 4 mg. K19Cre animals received three weeks of normal diet after the last tamoxifen injection before commencing the CDE diet regime.
BrdU (50 µg g −1 , Amersham) was administered by i.p. injection. Cholinedeficient ethionine-supplemented (CDE) protocols were as previously described 6, 31 . Recombinant murine TWEAK (R & D Systems) was delivered intravenously at 0.4 µg on days −5, −3, −1 and 1 in sterile PBS as previously described 32 . Mice were euthanized according to UK Home Office regulations. Unless livers were perfused, blood was collected by cardiac puncture. Organs were collected and stored following fixation in 10% formalin (in PBS) for 6 h or methacarn (60% methanol 30% chloroform 10% glacial acetic acid) for 24 h before embedding in paraffin blocks. Samples of liver were taken and snap frozen in an ethanol bath in dry ice in OCT media, RNAlater or directly for later analysis. Serum analysis used commercial kits according to the manufacturer's instructions for alanine transaminase (Alpha Laboratories), microalbumin (Olympus Diagnostics), aspartate aminotransferase and alkaline phosphatase (both Randox Laboratories).
Hepatocyte purification. Ex vivo primary cells were isolated using a modified retrograde perfusion technique 53 consisting of: Liver Perfusion Medium (Gibco) for 5 min; Liver Digest Medium (Gibco) for 10 min. The liver was then excised and the capsule disrupted to yield a cell suspension that was collected in Liver Perfusion Medium (Gibco) and passed through a 100 µm filter (BD Biosciences). Hepatocytes were pelleted by centrifugation at 135g for 1 min to separate them from a nonparenchymal cell (NPC)-rich fraction and each resuspended in Williams' E Medium (Gibco) with 5% FCS. The hepatocyte-rich cell suspension was then purified as described previously 53 . Briefly, cells were underlayered with a discontinuous Percoll gradient (1.06, 1.08 and 1.12 g ml −1 Percoll in PBS). Cells were then spun at 750g for 20 min at 20 • C. The cell layer collected between the 1.08 and 1.12 mg ml −1 Percoll layers was collected and resuspended in Williams' Medium. Cells were then purified a further 2 times using Percoll layers as previously, and quantified before analysis. Routinely, cells with hepatocyte morphology and expression of CYP2D6 (marker of hepatocellular differentiation) were obtained at over 99% purity (see Supplementary  Fig. 2 , P < 0.05).
HPC isolation. NPCs were retained from the supernatant following the initial 135g centrifugation step. Following red cell lysis (3 min in 160 mM NH 4 Cl, 10 mM KHCO 3 containing 0.01% EDTA), cells were re-suspended in Williams' E Medium (Gibco) with 10% FCS and underlayered with an equal volume of 20% and 50% (v/v) Percoll (Sigma) in PBS, respectively. Following centrifugation at 1,400g for 20 min at 4 • C, the HPC-rich fraction lying between the 20% and 50% Percoll layers (enriched for non-parenchymal cells) was collected, washed twice and resuspended in PBS with 2% FCS for FACS staining procedure. NPCs collected as described above were resuspended in PBS + 2% FCS before incubation with anti-mouse CD16/32 antibody (eBiosciences) for 10 min. After a wash with cold PBS, cells were resuspended in PBS + 2% FCS and were incubated with EpCAM-APCconjugated antibody (eBiosciences); CD24-PeCy7-conjugated antibody; CD133-FITC-conjugated antibody CD45-PE-conjugated antibody; CD31-PE-conjugated; Ter119-PE-conjugated antibody (Biolegend). Labelled cells were washed with PBS containing 2% FCS and analysed by FACS using a FACS Aria II (BD) with 488 nm and 640 nm lasers using a 100 µm nozzle. Haematopoietic cells (CD45+), erythroid cells (Ter119) and endothelial cells (CD31+) were excluded by gating. Immediately before sorting to exclude dead cells, 10 µg ml −1 7-aminoactinomycin D (7-AAD; Biolegend) was added. Cells were analysed and sorted with a FACS Aria II (BD). Trigger pulse width was used to exclude cell doublets from analysis and collection. Sorted cells were plated on rat tail collagen 1 (Sigma)-coated plates supplemented with previously published HPC expansion medium 8 . A step-bystep protocol describing the isolation and expansion of HPCs can be found at Protocol Exchange 54 .
Colony-forming assay. Cells were plated at clonal density (250 cells cm −2 ) on collagen-coated plates with culture medium. The number of colonies comprised of more than 50 cells was counted two weeks after plating. Number of colonies formed/number of wells plated = colony-forming efficiency.
Expansion of HPCs. Sorted HPCs were cultured in HPC Expansion Medium:
Williams' Medium E (Gibco) containing 10% FCS, 17.6 mM NaHCO 3 , 20 mM HEPES pH 7.5, 10 mM nicotinamide, 1 mM sodium pyruvate, 1 × insulin, transferrin, selenium solution (ITS) (Gibco), 100 nM dexamethasone, 0.2 mM ascorbic acid, 14 mM glucose, 10 ng ml −1 IL-6 (Peprotech), 10 ng ml −1 HGF (Peprotech), 10 ng ml −1 EGF (Sigma-Aldrich). Cultured HPCs were washed with PBS. Cells were then incubated with diluted trypsin (0.25% trypsin no EDTA, 20% Knockout Serum Replacement, 1 mM CaCl 2 ) at 37 • C. Williams' Medium E supplemented with 10% FCS was used to inhibit the reaction of trypsin. Cells were centrifuged at 300g for 5 min; supernatant was then discarded. Cells were resuspended in culture medium and replated on collagencoated plates. Table 2 for additional details. Cytospins and cells were fixed in cold methanol at 4 • C for 5 min before staining Species isotype (Santa Cruz) staining controls were routinely performed. Detection was performed with DAB (DAKO) followed by counterstaining with haematoxylin or alternatively with Alexa 488, 555 or 650 (A21206, A21434A21436/S32355, and A21448 respectively; Invitrogen) with a DAPI-containing Vectashield mounting media (Vector). Apoptosis was assessed using the DeadEnd Colorimetric or Fluorometric (Alexa 488) TUNEL System (Promega no. TB199) according to the manufacturer's instructions.
Microscopy and cell counting. Images were obtained on a Zeiss Axiovert 200 microscope using a Zeiss Axiocam MR camera. Cell counts were performed manually on blinded slides and more than 20 consecutive non-overlapping fields at ×200 or ×400 magnification. HPCs were defined as previously described and interlobular bile ducts were excluded from quantification 32 . Confocal image analysis was performed using a Leica SP5 system with the pinhole set to 1 airy unit. DAPI, Alexafluor 488 and 555 were detected using band paths of 415-480, 495-540 and 561-682 nm for 405, 488 and 543 nm lasers respectively. In vitro differentiation of HPCs. Murine recombinant Wnt3a (100 ng ml −1 ; R&D systems) and 1% dimethylsulphoxide (DMSO) were added to HPCs in combination with culture medium when cultured HPCs were 70% confluent. The differentiation process lasted for 6 days; medium was changed once in 3 days. Medium was kept for enzyme-linked immunosorbent assay (ELISA) and cells were lysed for RNA isolation. 
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consisted of around 10,000 cells per spheroid was cultured. The plate was then left in the incubator at 37 • C for 10 min for the Matrigel to set. Culture medium was then added to cover the Matrigel sphere. Spheres were cultured for 7 days and then analysed by immunocytochemistry.
GFP transfection of progenitor cell line and derivation of stably transfected lines. Qiagen Effectene was used for stable transfection. In vitro-expanded progenitor cells (5 × 10 5 ) were plated overnight. One microgram of vector with a puromycin-resistant CAG-GFP was used to stably transfect cells with GFP, provided by S. Lowell (University of Edinburgh, UK). Transfected cells were cultured for 3 days and GFP expression was detected with fluorescence microscopy. Around 10% of transfected cells expressed GFP after 4 days. The selection of stably transfected cells was carried with medium supplemented with 3 µg ml −1 puromycin for 14 days and colonies were picked with cloning rings and grown to generate clonally derived stably transfected lines. GFP expression of stably transfected lines was constantly monitored with fluorescence microscopy.
ELISA detection of albumin. Conditioned medium from cultured cells was stored at −80 • C for further analysis. Stored medium was thawed at room temperature and tested for albumin concentration using the Mouse Albumin ELISA Quantification Set following the manufacturer's protocol. A standard curve was generated using supplemented kits with different concentrations of albumin. Absorbance at 450 nm of was read using a spectrophotometer (SPECTROstar Omega).
Analysis of cell area, roundness, and ratio of width to length. Cell area, roundness, and ratio of width to length were analysed using the Operetta highcontent analysis system (PerkinElmer). Data analysis was performed using the Columbus image data storage and analysis system.
Karyotyping of cells.
Colcemid (Gibco) was added to the cultured cells for 18 h. Cells were then trypsinized, washed with PBS and resuspended with 75 mM KCl (Gibco) and incubated for 15 min at room temperature. Cells were then resuspended in fixatives (3:1 methanol and acetic acid). Cells were washed and spread on glass slides. Slides were mounted with DAPI fluoromount (Southern Biotech). The number of chromosomes was counted using fluorescence microscopy.
Real-time PCR and gene expression analysis. Genomic DNA (gDNA) was extracted from purified cell populations from whole liver using the DNA Blood Mini Kit (Qiagen). Total RNA was extracted from 30-50 mg tissue samples previously stored in RNAlater at −80 • C or cultured cells, using a combination of TRIzol reagent (Invitrogen) and Qiagen RNeasy Mini system according to the manufacturer's instructions (Qiagen). Reverse-transcription (including gDNA decontamination) and real-time PCR was performed using reagents and primers (Quantifast and Quantitect respectively, Qiagen) on a Roche Lightcycler 480. Mdm2 flox integrity of gDNA was assessed using primers targeted to the floxed segment (forward: 5 -ACGAGAAGCAGCAGCACATTG-3 , reverse: 5 -TTATAACCCACCACGCACAAGG-3 ) and a reference segment adjacent to exon 3 (forward: 5 -AACCTGGATTATCGCACAGTCG-3 , reverse: 5 -TCGC AGTGACCACTCTCTAATGC-3 ). Data were analysed using the LightCycler system following normalization to the housekeeping gene peptidylprolyl isomerase A (Ppia). All samples were run in triplicate.
Statistical analysis. Samples were randomized by a 'blinded' third party before being assessed separately by a 'blinded' assessor. Unblinding was performed immediately before final data analysis. Prism software (GraphPad Software) was used for all statistical analysis. Mean HPCs per ×200 magnification field from 30 fields for each mouse were compared. Data are presented as mean ± s.e.m. n refers to biological replicates. Normal distribution of data was determined using the D' Agostino and Pearson omnibus normality test. For parametric data, data significance was analysed using a two-tailed unpaired Student's t-test. In cases where more than two groups were being compared, then a one-way ANOVA was used. In instances where the n was too small to determine normal distribution or the data were non-parametric then a two-tailed Mann-Whitney U -test was used. F-tests were used to compare variances between groups.
Reproducibility of experiments. Routinely, qPCR experiments were performed in technical triplicates when possible. For representative images whole liver lobes were examined histologically in multiple biological replicates. For 
